News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Tachi Yamada's biotechs are continuing to make news.
Three start-up companies will be the first to receive investment from the Fund for Health, a joint partnership between Penn Medicine and the Wharton Social Impact Initiative.
PCI is proud to announce that Penn is one of the schools chosen to participate in the National Science Foundation’s new innovative I-Corps Hub initiative.
In August 2021, the Pennovation Accelerator, an annual six week program that teaches local startups about business development, named two winners for its Pitch Day event.
The award, one of the largest in medicine and science in the U.S., has been given for the last 20 years by Albany Medical Center to those who have altered and positively impacted the course
The U.S. FDA has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists at Penn.
Technological improvements have changed the incentives of individuals to start their own business.
Penn Engineers and their colleagues showed that the proton conductivity of their new fluorine-free polymer increases with water content and exceeds that of Nafion, the current industry standard.
To address cost, time and accuracy, a new electrochemical test developed by Penn researchers uses electrodes made from graphite—the same material found in pencil lead.
Penn Dental Medicine and Penn Engineering, which teamed earlier this year to launch the Center for Innovation and Precision Dentistry (CiPD), recently awarded the Center’s first IDEA Prize.